Evidence map›Paper›PMID 33645543›Full record

ArticleThe Journal of clinical investigation2021

From the gut to bone: connecting the gut microbiota with Th17 T lymphocytes and postmenopausal osteoporosis.

Joseph Lorenzo

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Joseph Lorenzo
UConn Health · US

Funding

Studies of Osteoclast Lineage in Health and DiseaseR56AR074391 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LORENZO, JOSEPH A · 2019 to 2019
$412k
Parmodulins as an Anti-Resorptive and Anti-Inflammatory Therapy for Metabolic Bone DiseaseR21AR076671 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LORENZO, JOSEPH A · 2020 to 2021
$391k
NIAMS NIH HHS R21 AR076671NIAMS NIH HHS R56 AR074391
6 · The paper itself

Abstract

Osteoporosis is a serious clinical problem that often follows the accelerated bone loss that occurs after the estrogen withdrawal of menopause. In order to better understand the mechanism that produces estrogen withdrawal-induced bone loss, Yu and Pal et al., as reported in this issue of the JCI, examined mice that underwent ovariectomy (OVX). In C57BL/6 mice with enhanced Th17 cells in gut tissue, the authors demonstrated that OVX increased migration of TNF-expressing Th17 cells from the gut to the bone marrow. Furthermore, they found that manipulation of the pathways by which lymphocytes migrate and home to bone marrow prevented the increase of TNF+, Th17 cells in bone marrow after OVX in mice and the trabecular, but not cortical, bone loss in this model. These results argue that interactions of the gut microbiota with the immune system are involved in the effects of estrogen withdrawal on trabecular bone.

Indexed as

Gastrointestinal MicrobiomeOsteoporosis, PostmenopausalAnimalsBone and BonesFemaleHumansMiceMice, Inbred C57BLOvariectomyTh17 Cells

Identifiers

PMID33645543
PMCPMC7919711
OpenAlexW3133981053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.